Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia

This publication has 27 references indexed in Scilit:

• Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
  New England Journal of Medicine, 2000
• Pathogenesis of secondary hyperparathyroidism
  Kidney International, 1999
• The hyperparathyroidism of chronic renal failure: A disorder of growth
  Kidney International, 1997
• A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content
  American Journal of Kidney Diseases, 1997
• Regulation of parathyroid cell proliferation
  Current Opinion in Nephrology and Hypertension, 1997
• Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure
  American Journal of Kidney Diseases, 1996
• Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.
  Journal of Clinical Investigation, 1996
• A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia
  American Journal of Kidney Diseases, 1995
• Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
  Journal of Clinical Investigation, 1995
• 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia
  Kidney International, 1989